Krsnaa Diagnostics Limited has informed the Exchange regarding Change in Director(s) of the company.
KRSNAA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Krsnaa Diagnostics has approved the re-appointment of Mr. Rajendra Khivraj Mutha as Whole-time Director and Executive Chairman for a fresh 5-year term from April 26, 2026 to April 25, 2031. The decision was taken on the recommendation of the Nomination and Remuneration Committee and is subject to shareholder approval through a postal ballot. Mr. Mutha has over two decades of experience in pharmacy and diagnostics and continues to lead the company's CSR and community health initiatives. He is not related to any other director on the board and is not debarred from holding office by any authority.
This is a continuity move with no change in leadership, which is generally viewed as a neutral-to-slightly-positive signal for shareholders. The re-appointment still requires shareholder approval via postal ballot before it becomes effective.